CX Alternative-backed clinical research firm Veeda to raise over $111m via IPO

CX Alternative-backed clinical research firm Veeda to raise over $111m via IPO

Ravindra Sonavane

30 September, 2021

CX Alternative Investment Fund ICICI Securities SBI Capital markets Veeda Clinical Research Ltd

Printed by Unregistered user on Sat, 06 Dec 2025 17:13:42 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

PE-backed Veeda Clinical Research buys majority stake in Bioneeds India

India: PE firm CX Partners looks to divest stake in Veeda through IPO

Read more from India

Meesho raises $28b in India IPO as institutional investors pile in

Zoho, Lingotto pump $45m into Indian electric bike company Ultraviolette